淋巴结比率与转移淋巴结数目对喉鳞状细胞癌生存和复发的影响
这项回顾性多中心国际研究纳入24个耳鼻咽喉头颈外科中心的2507例喉鳞状细胞癌患者,评估淋巴结比率(LNR)和阳性淋巴结数目(NPLN)对疾病特异性生存(DSS)和无病生存(DFS)的影响。按LNR和NPLN分层的患者DSS和DFS存在显著差异,基于LNR和NPLN的5年DSS和DFS分层能力优于pN分期。数据表明NPLN和LNR在喉鳞状细胞癌中具有潜在预后价值。
要点
- 按LNR和NPLN分层的喉鳞状细胞癌患者DSS和DFS存在显著差异。
- 基于LNR和NPLN的5年DSS和DFS分层能力优于pN分期。
- NPLN和LNR在喉鳞状细胞癌中具有潜在预后价值。
核心结论
- 数据表明NPLN和LNR在喉鳞状细胞癌中具有潜在预后价值。
研究设计与样本
- 回顾性多中心国际研究,涉及24个耳鼻咽喉头颈外科部门,2507例患者符合纳入标准。
主要发现
- 按LNR和NPLN分层的患者组间DSS和DFS存在显著差异。
- 基于LNR和NPLN的5年DSS和DFS与pN分期相比显示出更好的患者分层能力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The aim of this study is to assess the impact of lymph node ratio (LNR) and number of positive lymph nodes (NPLN) on mortality and recurrence rates in patients with laryngeal squamous cell carcinoma. MATERIALS AND METHODS: We conducted a retrospective multicenter international study involving 24 Otorhinolaryngology-Head and Neck Surgery divisions. Disease-specific survival (DSS) and disease-free survival (DFS) were evaluated as the main outcomes. The curves for DSS and DFS according to NPLN and LNR were analyzed to identify significant variations and establish specific cut-off values. RESULTS: 2507 patients met the inclusion criteria. DSS and DFS were significantly different in the groups of patients stratified according to LNR and NPLN. The 5-year DSS and DFS based on LNR and NPLN demonstrated an improved ability to stratify patients when compared to pN staging. CONCLUSION: Our data demonstrate the potential prognostic value of NPLN and LNR in laryngeal squamous cell carcinoma.
引用
- Molteni G, Nocini R, Mattioli F, et al. Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma. Head Neck. 2023. PMID: 37496499. doi:10.1002/hed.27471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。